0.00Open0.05Pre Close0 Volume161 Open Interest2.50Strike Price0.00Turnover8656.67%IV150.00%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1730Delta0.3599Gamma20.40Leverage Ratio-4.0116Theta0.0000Rho3.53Eff Leverage0.0000Vega
Connect Biopharma Stock Discussion
NEWS
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
Price target for this stock is 7$ its undervalued .. sooner it will jump to 2.5 to 3$
No comment yet